Trial intelligence / Profile preview

Vitamin D in Chronic Heart Failure

NCT01092130Phase 2Completed

Sponsor
University Medical Center Groningen
Start
Mar 2010
Primary completion
Mar 2012
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 2, randomised, open-label trial of vitamin d in chronic heart failure (CHF) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Plasma Renin Activity at 6 weeks. Started Mar 2010; status: completed.

02

Drugs

vitamin d
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on NCT01092130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01092130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call